Form 4: BioCorRx Inc. Director Louis C. Lucido Reports Acquisition of Shares

Louis C. Lucido, a director, 10% owner, and President of BioCorRx Inc., reports the acquisition of 44,220 shares of common stock on June 28, 2024, due to director and executive service agreements.

Summary

• On June 28, 2024, Louis C. Lucido, a director, 10% owner, and President of BioCorRx Inc. (BICX), acquired a total of 44,220 shares of the company's common stock.
• 10,204 shares were issued under a Director Agreement dated March 1, 2019, as compensation for his services as a board member.
• These shares are equivalent to $5,000, calculated based on the average closing price of $0.49 on the three trading days preceding the transaction date.
• An additional 34,016 shares were issued under an Executive Service Agreement dated January 5, 2024, as compensation for his services.
• These shares are equivalent to $16,667, also calculated based on the average closing price of $0.49 on the three trading days preceding the transaction date.
• Following these transactions, Mr. Lucido directly owns 622,816 shares of BioCorRx Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a key executive is generally a good sign, but it's part of a pre-existing compensation agreement, so it's not necessarily indicative of a major shift in sentiment.

Positives

• The acquisition of shares by a director and officer could be seen as a positive sign, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings in the company.

Stakeholder Impact

• The share issuance will slightly dilute existing shareholders' ownership.

Key Dates

Keywords

BioCorRx Inc., Louis C. Lucido, share acquisition, Form 4, director compensation, executive compensation, BICX